Complement Inhibitor [EPC]

56259 reported adverse events

Drugs of this class: PEGCETACOPLAN ECULIZUMAB ECULIZUMAB-AAGH ECULIZUMAB-AEEB POZELIMAB RAVULIZUMAB

These side effects are most commonly reported by patients taking drugs of the Complement Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 7706
1 OFF LABEL USE 5469
2 HAEMOGLOBIN DECREASED 4403
3 HEADACHE 4261
4 DEATH 3439
5 ASTHENIA 2944
6 PYREXIA 2745
7 DYSPNOEA 2725
8 DRUG INEFFECTIVE 2685
9 NAUSEA 2346
See all common reactions for Complement Inhibitor [EPC]

Drugs of the Complement Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREAKTHROUGH HAEMOLYSIS 350 0.8772
1 TOTAL COMPLEMENT ACTIVITY DECREASED 53 0.8689
2 EXTRAVASCULAR HAEMOLYSIS 347 0.8165
3 TOTAL COMPLEMENT ACTIVITY INCREASED 42 0.7925
4 HAEMOGLOBINURIA 740 0.6601
5 HAPTOGLOBIN ABNORMAL 52 0.5652
6 MENINGOCOCCAL SEPSIS 105 0.5526
7 MENINGOCOCCAL BACTERAEMIA 52 0.5417
8 COMPLEMENT FACTOR ABNORMAL 54 0.5047
9 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 228 0.4861
See all enriched reactions for Complement Inhibitor [EPC]